|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|
| Cash flows used in operating activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization | |
| General and Administrative Expense | |
| Restructuring Charges | |
| Total depreciation and amortization | |
| Stock based compensation expense | |
| Other | |
| Changes in assets and liabilities: | |
| Accounts receivable, net | |
| Prepaid expenses and other current assets | |
| Inventory, net | |
| Other assets | |
| Accounts payable | |
| Accrued expenses | |
| Deferred revenue | |
| Other liabilities | |
| Net cash used in operating activities | |
| Cash flows used in investing activities: | |
| Purchases of property and equipment | |
| Accounts Payable | |
| Total purchases of property and equipment | |
| Note receivable | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Exercise of stock options | |
| Proceeds from Fundraising | |
| Proceeds from borrowings | |
| Repayment on borrowings | |
| Payment of deferred financing costs | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes | |
| Net change in cash, cash equivalents and restricted cash | |
| Cash, cash equivalents and restricted cash at beginning of period | |
| Cash, cash equivalents and restricted cash at end of the period | |
| Supplemental disclosure of cash paid for: | |
| Interest paid | |
| Amount converted to common stock | |
| Series seed preferred stock | |
| Series A preferred stock | |
| Series B preferred stock | |
| Series C preferred stock | |
| Series D preferred stock | |
| Reclass of deferred financing costs to additional paid in capital | |
| Supplemental reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets. | |
| Cash and cash equivalents | |
| Restricted cash |
Loading...
